Latest News about NASDAQ:LGVN
Recent news which mentions NASDAQ:LGVN
Tickers
LGVN
From InvestorPlace
Tickers
LGVN
From InvestorPlace
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 12, 2023
Tags
NASDAQ:LGVN
From News Direct
Upcoming Phase 2 Data Expected For Longeveron’s (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer’s Sector – What To Look For
September 07, 2023
Tags
NASDAQ:LGVN
From News Direct
Tags
NASDAQ:LGVN
From News Direct
Tickers
LGVN
From InvestorPlace
Why Longeveron’s Good News Isn’t Telling Us the Whole Truth
December 10, 2021
Tickers
LGVN
From InvestorPlace
Even After a Blistering Rally, Longeveron Is Still Buyable
November 30, 2021
Tickers
LGVN
From InvestorPlace
LGVN Stock: 7 Things to Know as Longeveron Rockets 100% Higher
November 24, 2021
Tickers
LGVN
From InvestorPlace
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
November 18, 2021
Tickers
LGVN
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.